SMEs

DREAMINSIGHT Co.,Ltd. Begins Full-Scale Implementation of ‘DMAX AI’… Strengthening Competitiveness in Advertising and Marketing

KIM JI-WAN
2026-09-21 08:55:06
[Edaily Reporter KIM JI-WAN ] DREAMINSIGHT Co.,Ltd.(362990)announced on the 21st that it has begun applying its self-developed artificial intelligence (AI) platform, “DMAX AI,” to actual advertising operations and is simultaneously providing AI training to its employees to strengthen the competitiveness of its marketing business.

DREAMINSIGHT Co.,Ltd.’s in-house artificial intelligence (AI) platform, “DMAX AI.”

As the scope of AI utilization rapidly expands across the advertising and media industries, DREAMINSIGHT Co.,Ltd. plans to improve operational efficiency and advertising performance by simultaneously advancing its in-house technology development and enhancing the organization’s AI capabilities.

DMAX AI, built by the company, is an AI-based marketing solution designed to handle advertising planning, content production, campaign management, and performance analysis all on a single platform. It was developed to enable advertisers and agencies to comprehensively manage all aspects of advertising operations, and the company is currently conducting performance verification and refinement for each feature.

Some features have already been implemented in advertising campaigns run by DREAMINSIGHT Co.,Ltd. The system automates the collection and processing of advertising data—tasks previously handled manually by staff—and is used to identify and analyze underperforming ad creatives and keywords.

The company explained that it has confirmed these measures reduce repetitive tasks and increase the speed and productivity of advertising operations. After further verifying performance and stability through internal implementation, the company plans to expand its business scope to offer the solution to external companies and brands.

In tandem with the adoption of AI technology, the company is also working to enhance employees’ practical skills in applying these technologies.

Last August, DREAMINSIGHT Co.,Ltd. conducted a total of five “Generative AI Marketing” training sessions for employees at its Seoul headquarters, Gangnam office, and Busan branch. The training consisted of three in-person sessions and two online sessions, each lasting eight hours.

The curriculum went beyond simply introducing the concepts and usage of generative AI to focus on actual marketing tasks. It was structured around hands-on exercises to enable employees to utilize AI in their daily work processes, including content planning, market and competitor research, and data analysis.

DREAMINSIGHT Co.,Ltd. plans to expand the scope of DMAX AI’s application while embedding employees’ AI proficiency throughout the organization. The company envisions using AI not merely as a tool to assist with tasks, but as a core tool to reduce advertising operating costs and support clients’ marketing decision-making.

Kim Ki-cheol, CEO of DREAMINSIGHT Co.,Ltd., stated, “AI is establishing itself as a core technology that is transforming the way the advertising and marketing industries operate and reshaping the competitive landscape. DREAMINSIGHT Co.,Ltd.’s DMAX AI platform is expected to improve operational efficiency internally, leading to cost savings. Externally, it enables predictive analysis of clients’ advertising and marketing campaigns, allowing for more rational and strategic choices that enhance advertising efficiency,” he said. “Based on our proprietary technology and organizational capabilities, we will proactively respond to the AI transformation and leverage it to create new business opportunities and drive mid- to long-term growth.”

Economy

Corporation

IT·Science

Economy

Lisa Su Meets with Jeon Young-hyun for 3 Hours… “Broad Partnership” for Foundry Collaboration

Lisa Su, Chairwoman and CEO of AMD, concluded a meeting lasting over three hours with Jeon Young-hyun, President and CEO of SamsungElectronics and Vice Chairman in charge of the Device Solutions (DS) …
2026-10-07 20:35:47

Corporation

South Korea Enters the 160 Trillion Global Obesity Drug Market… HanmiGlobal Co., Ltd’s “Epe” Becomes First Domestically Developed Drug to Receive Approval

Epfeglenatide, developed by HanmiPharm, has received approval from the Ministry of Food and Drug Safety as the first domestically developed GLP-1-based obesity treatment. With this approval, Korea has…
2026-10-07 19:34:02

IT·Science

A Twist in the Story of the New Drug Rejected by Sanofi… Hanmi’s “Epe” Becomes the First Domestically Developed GLP-1 Weight-Loss Drug to Receive Approval

A new domestically developed drug has emerged to compete in the obesity treatment market, which is currently dominated by global pharmaceutical companies. With HanmiPharm’s efeglenatide receiving mark…
2026-10-07 18:22:02